Publications

Date: 2020-04-25

Titre: The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.

Auteurs: Armstrong J, Beck LA, Bieber T, Bissonnette R, Chavda R, DeLozier AM, Dubost-Brama A, Dutronc Y, Eichenfield L, Feldman SR, Frey S, Guttman E, Janes JM, Joubert Y, Kabashima K, King B, Klekotka P, Lin CY, Mallbris L, Martel P, Menter A, Milutinovic M, Nickoloff B, Nunes F, Paller A, Parneix A, Paul C, Reich K, Seyger M, Siegfried E, Silverberg JI, Simpson E, Stingl G, Sun L, Teixeira HD, van de Kerkhof P, Yosipovitch G

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2020-03-14

Titre: ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation.

Auteurs: Bissonnette R, Dong C, Galand C, Geha RS, Leyva-Castillo JM, Mashiko S, McGurk A, McKenzie ANJ, Sarfati M, Ziegler SF

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2020-01-05

Titre: Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.

Auteurs: Beck LA, Bieber T, Bissonnette R, Brinker DR, Cardillo T, Costanzo A, DeLozier AM, Eichenfield LF, Galimberti R, Gamalo M, Guttman-Yassky E, Janes JM, Kabashima K, King BA, Lacour JP, Nunes FP, Paller AS, Reich K, Silverberg JI, Simpson EL, Spelman L, Thyssen JP, Tsunemi Y, Wollenberg A

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2019-12-26

Titre: Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.

Auteurs: Akinlade B, Ardeleanu M, Beck LA, Beissert S, Bissonnette R, Chan KC, Chen Z, Davis JD, Eckert L, Ferrandiz C, Gadkari A, Graham NMH, Hultsch T, Kawashima M, Lacour JP, Pirozzi G, Rajadhyaksha M, Simpson EL, Smith CH, Stahl N, Staudinger H, Thaçi D, Worm M, Yancopoulos GD

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2019-12-03

Titre: Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.

Auteurs: Bissonnette R, Bitton A, Bressler B, Gooderham M, Haraoui B, Ho V, Jamal S, Kumar D, Marshall JK, Papp KA, Pope JE, Steinhart AH, Vinh DC, Wade J

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2019-11-13

Titre: Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial

Auteurs: Bissonnette R, Diaz A, Estrada YD, Guttman-Yassky E, Pavel AB, Ports WC, Purohit VS, Saint-Cyr Proulx E, Vlahos B, Vranic I, Werth JL, Zang C, Zielinski MA

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-11-09

Titre: Persistence of inflammatory phenotype in residual psoriatic plaques in patients on effective biologic therapy: Residual Psoriatic Plaques After Treatment

Auteurs: Bissonnette R, Bi Y, Cao X, Edelmayer RM, Garcet S, Huang SM, Kaimal V, Kannan AK, Krueger JG, Liu Z, Li X, Maari C, Mashiko S, Olson LM, Saint-Cyr Proulx E, Salte K, Sarfati M, Smith KM., Wang J, Wetter JB

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2019-10-04

Titre: Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

Auteurs: Bissonnette R, Del Duca E, Denis L, Dubin C, Estrada YD, Gupta S, Guttman-Yassky E, Kim HJ, Krueger JG, Pavel AB, Peng X, Rao N, Song T, Xu H, Zammit DJ, Zhang N

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2019-10-02

Titre: Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial

Auteurs: Banfield C, Beebe JS, Bissonnette R, Forman SB, Gooderham MJ, Papacharalambous J, Peeva E, Vincent MS, Zhang W, Zhu L

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-09-10

Titre: Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis

Auteurs: Bissonnette R, Gooderham M, Hong CH

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-08-12

Titre: Incidence of Cardiovascular Events Among Tildrakizumab-Treated Patients with Moderate to Severe Plaque Psoriasis: Pooled Data from 3 Large Randomised Clinical Trials

Auteurs: Bissonnette R, Fernández-Peñas P, Mendelsohn AM, Menter A, Puig L, Rozzo SJ

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2019-07-30

Titre: Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study

Auteurs: Akinlade B, Ardeleanu M, Beck LA, Bissonnette R, Blauvelt A, Bouaziz JD, Chen Z, Davis JD, de Bruin-Weller M, Deleuran M, Eckert L, Foley P, Forman S, Gadkari A, Gelfand JM, Graham NMH, Hide M, Hussain I, Pirozzi G, Rajadhyaksha M, Reich K, Schuttelaar MLA, Sher L, Soong W, Staudinger H, Thaçi D, Wang C

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-07-26

Titre: Oral JAK/SYK-inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in atopic dermatitis.

Auteurs: Bissonnette R, Del Duca E, Denis L, Dubin C, Estrada Y, Gupta S, Guttman-Yassky E, Kim HJ, Krueger JG, Pavel AB, Peng X, Rao N, Song T, Xu H, Zammit DJ, Zhang N

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-06-25

Titre: IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.

Auteurs: Ardeleanu M, Bissonnette R, Callewaert C, Gallo RL, Graham NMH, Guttman-Yassky E, Hamilton JD, Hultsch T, Knight R, Kosciolek T, Kotol P, Krueger J, Menter A, Nakatsuji T, Pirozzi G, Silverberg JI, Vrbanac A

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-06-17

Titre: Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.

Auteurs: Barankin B, Bissonnette R, Chavda R, Dreno B, Gagné-Henley A, Kerrouche N, Lynde C, Tan J

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2019-05-03

Titre: Major differences in expression of inflammatory pathways in skin from different body sites of healthy individuals.

Auteurs: Bissonnette R, Brezinski Wallace E, Del Duca E, Dubin C, Estrada YD, Guttman-Yassky E, Jack C, Krueger JG, Maari C, Pavel AB, Peng X, Song T, St-Cyr Proulx E, Xu H

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2019-03-29

Titre: The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study.

Auteurs: Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D, Sofen H, Dhawan S, Zook M, Zammit DJ, Usansky H, Denis L, Rao N, Song T, Pavel AB, Guttman-Yassky E

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-03-12

Titre: Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement.

Auteurs: Bissonnette R, Cork MJ, Guttman-Yassky E, Irvine AD, Leshem YA, Paller AS, Paul C, Silverberg JI

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-02-10

Titre: GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.

Auteurs: Guttman-Yassky E, Pavel AB, Zhou L, Estrada YD, Zhang N, Xu H, Peng X, Wen HC, Govas P, Gudi G, Ca V, Fang H, Salhi Y, Back J, Reddy V, Bissonnette R, Maari C, Grossman F, Wolff G

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2019-02-09

Titre: Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Randomised Phase 2 Study.

Auteurs: Reich K, Rich P, Maari C, Bissonnette R, Leonardi C, Menter A, Igarashi A, Klekotka P, Patel D, Li J, Tuttle J, Morgan-Cox M, Edson-Heredia E, Friedrich S, Papp K; AMAF investigators

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2019-01-08

Titre: Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis.

Auteurs: Robbins K, Bissonnette R, Maeda-Chubachi T, Ye L, Peppers J, Gallagher K, Kraus JE

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2019-01-01

Titre: Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council

Auteurs: Bieber T, Bissonnette R, Brown SJ, Dhar S, Eyerich K, Guttman-Yassky E, Hijnen DJ, Irvine A, Paller AS, Perez White BE, Reynolds NJ, Tanaka RJ, Thyssen JP, Vestergaard C, Werfel T, Wollenberg A

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2018-11-23

Titre: Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Auteurs: Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2018-11-16

Titre: Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis.

Auteurs: Hong CH, Gooderham MJ, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2018-11-16

Titre: Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document.

Auteurs: Gooderham MJ, Hong CH, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2018-11-16

Titre: Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis.

Auteurs: Gooderham MJ, Bissonnette R, Grewal P, Lansang P, Papp KA, Hong CH

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2018-10-17

Titre: The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition.

Auteurs: Guttman-Yassky E, Hanifin JM, Boguniewicz M, Wollenberg A, Bissonnette R, Purohit V, Kilty I, Tallman AM, Zielinski MA

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2018-09-19

Titre: Ultraviolet B induced immunosuppression is not associated with RANKL upregulation in human skin.

Auteurs: Saint-Cyr Proulx E, Mashiko S, Maari C, Bolduc C, Nigen S, Sarfati M, Bissonnette R

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2018-09-06

Titre: The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.

Auteurs: Tan J, Bissonnette R, Gratton D, Kerrouche N, Canosa JM

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2018-09-05

Titre: Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients.

Auteurs:

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2018-05-21

Titre: Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.

Auteurs: Valenzuela F, Korman NJ, Bissonnette R, Bakos N, Tsai TF, Harper MK, Ports WC, Tan H, Tallman A, Valdez H, Gardner AC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2018-05-10

Titre: Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled Phase 3b Study of Patients with Moderate-to-Severe Genital Psoriasis.

Auteurs:

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2018-04-19

Titre: Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.

Auteurs: Dréno B, Bissonnette R, Gagné-Henley A, Barankin B, Lynde C, Kerrouche N, Tan J

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2018-03-19

Titre: Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial.

Auteurs: Czarnowicki T, Dohlman AB, Malik K, Antonini D, Bissonnette R, Chan TC, Zhou L, Wen HC, Estrada Y, Xu H, Bryson C, Shen J, Lala D, Ma'ayan A, McGeehan G, Gregg R, Guttman-Yassky E

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2018-02-14

Titre: Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study).

Auteurs: Bissonnette R, Luger T, Thaçi D, Toth D, Lacombe A, Xia S, Mazur R, Patekar M, Charef P, Milutinovic M, Leonardi C, Mrowietz U

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2018-02-01

Titre: Topical Vitamin E Cream Does Not Prevent Visible Light-Induced Pigmentation.

Auteurs: Mereniuk A, Marchessault P, Maari C, Bolduc C, Bissonnette R

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2018-02-01

Titre: Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study.

Auteurs: Bissonnette R, Vasist LS, Bullman JN, Collingwood T, Chen G, Maeda-Chubachi T

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2018-02-01

Titre: JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.

Auteurs: Bissonnette R

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2017-11-15

Titre: Apremilast for the treatment of moderate to severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study

Auteurs: Bissonnette R, Haydey R, Rosoph L, Lynde CW, Bukhalo M, Fowler J, Delorme I, Gagné-Henley A, Gooderham M, Poulin Y, Barber K, Jenkin P, Landells I, Pariser D

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-10-21

Titre: A Phase 2a Randomized Controlled Study to Evaluate the Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topically Applied Umeclidinium in Subjects with Primary Axillary Hyperhidrosis

Auteurs: Nasir A, Bissonnette R, Maari C, DuBois J, Pene Dumitrescu T, Haddad J, Yamaguchi Y, Dalessandro M

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2017-10-01

Titre: Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis

Auteurs: Bissonnette R, Kerdel F, Naldi L, Papp K, Galindo C, Langholff W, Tang KL, Szapary P, Fakharzadeh S, Srivastava B, Goyal K, Gottlieb AB

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-10-01

Titre: Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasis

Auteurs: Bissonnette R, Tamaz R, Bolduc C, Maari C, Robillard C, Nigen S, Delorme I, Lynde C

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-08-29

Titre: Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.

Auteurs: Bissonnette R, Bourcier M, Gooderham M, Hong CH, Landells I, Lynde C, Papp K, Poulin Y, Vender R, Wiseman MC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-08-01

Titre: The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis

Auteurs: Merola JF, Bleakman AP, Gottlieb AB, Menter A, Naegeli AN, Bissonnette R, Guenther L, Sullivan J, Meeuwis K, See K, Duffin KC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-07-31

Titre: Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and in?uence of body surface area on usage

Auteurs: Bissonnette R, Carvalho AVE, Iversen L, Kirby B, Kleyn CE, Lange MM, Lynde CW, van de Kerkhof PC, van der Walt JM, Wu JJ

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-07-15

Titre: Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis

Auteurs: Mashiko S, Mehta H, Bissonnette R, Sarfati M

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2017-07-01

Titre: Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy

Auteurs: Jack C, Mashiko S, Arbour N, Bissonnette R, Sarfati M

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-06-05

Titre: Secukinumab Sustains Good Efficacy and Favourable Safety in Moderate to Severe Psoriasis up to 3 Years of Treatment: Results from A Double-Blind Extension Study

Auteurs: Bissonnette R, Luger T, Thaçi D, Toth D, Messina I, You R, Guana A, Fox T, Papavassilis C, Gilloteau I, Mrowietz U

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-06-01

Titre: Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular Erythema

Auteurs: Tan J, Bourdès V, Bissonnette R, Petit B Eng L, Reynier P, Khammari A, Dreno B

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2017-04-03

Titre: Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial.

Auteurs: Dreno B, Tan J, Rivier M, Martel P, Bissonnette R

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2017-03-17

Titre: Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis.

Auteurs: Bissonnette R, Cademartiti F, Maffei E, Tardif JC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-03-09

Titre: TNF-alpha antagonist and vascular inflammation in patients with psoriasis vulgaris: a randomized placebo-controlled study.

Auteurs: Bissonnette R, Harel F, Krueger JG, Guertin MC, Chabot-Blanchet M, Gonzalez J, Maari C, Delorme I, Lynde CW, Tardif JC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-03-07

Titre: Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data.

Auteurs: Strober B, Leonardi C, Papp KA, Mrowietz U, Ohtsuki M, Bissonnette R, Ferris LK, Paul C, Lebwohl M, Braun DK, Mallbris L, Wilhelm S, Xu W, Ljungberg A, Acharya N, Reich K

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-02-24

Titre: Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.

Auteurs: Guttman-Yassky E, Ungar B, Malik K, Dickstein D, Suprun M, Estrada YD, Xu H, Peng X, Oliva M, Todd D, Labuda T, Suarez-Farinas M, Bissonnette R

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2017-01-08

Titre: Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway.

Auteurs: Bissonnette R, Fuentes-Duculan J, Mashiko S, Li X, Bonifacio KM, Cueto I, Suárez-Fariñas M, Maari C, Bolduc C, Nigen S, Sarfati M, Krueger JG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2017-01-07

Titre: Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study.

Auteurs: Bissonnette R, Poulin Y, Drew J, Hofland H, Tan J

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2016-12-06

Titre: Use of Lesion Response Rate in Actinic Keratosis Trials.

Auteurs: Szeimies RM, Atanasov P, Bissonnette R

Categorie: Actinic Keratoses


Lire cette publication sur PUBMED

Date: 2016-11-17

Titre: Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.

Auteurs: Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman M, Mallbris L, Wang C, Purohit V, Mamolo C, Papacharalambous J, Ports WC

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2016-11-13

Titre: The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.

Auteurs: Kim J, Bissonnette R, Lee J, Correa da Rosa J, Suárez-Fariñas M, Lowes MA, Krueger JG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-10-03

Titre: Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.

Auteurs: Papp KA, Bissonnette R, Gooderham M, Feldman SR, Iversen L, Soung J, Draelos Z, Mamolo C, Purohit V, Wang C, Ports WC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-08-27

Titre: A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis

Auteurs: Bissonnette R, Luchi M, Fidelus-Gort R, Jackson S, Zhang H, Flores R, Newton R, Scherle P, Yeleswaram S, Chen X, Menter A

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-07-30

Titre: Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis Council

Auteurs: Wu JJ, Lynde CW, Kleyn CE, Iversen L, van der Walt JM, Carvalho A, Kirby B, Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-07-16

Titre: Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial

Auteurs: Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman M, Mallbris L, Wang C, Purohit V, Mamolo C, Papacharalambous J, Ports WC

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2016-07-07

Titre: Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis

Auteurs: Bissonnette R, Pariser DM, Wasel NR, Goncalves J, Day RM, Chen R, Sebastian M

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-07-02

Titre: Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris

Auteurs: Bissonnette R, Suárez-Fariñas M, Li X, Bonifacio KM, Brodmerkel C, Fuentes-Duculan J, Krueger JG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-05-20

Titre: Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity

Auteurs: Richer V, Roubille C, Fleming P, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Gulliver WP, Haraoui B, Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-05-13

Titre: The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes

Auteurs: Kim J, Bissonnette R, Lee J, Correa da Rosa J, Suárez-Fariñas M, Lowes MA, Krueger JG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-05-07

Titre: Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).

Auteurs: Strober BE, Bissonnette R, Fiorentino D, Kimball AB, Naldi L, Shear NH, Goyal K, Fakharzadeh S, Calabro S, Langholff W, You Y, Galindo C, Lee S, Lebwohl MG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-05-06

Titre: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris

Auteurs: Bissonnette R, Suárez-Fariñas M, Li X, Bonifacio KM, Brodmerkel C, Fuentes-Duculan J, Krueger JG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2016-05-04

Titre: Dr. Roubille, et al reply

Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFARLANE A, Fleming P, Siu S, Kraft J, Lynde C, Pope JE, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2016-04-06

Titre: Systematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agent

Auteurs: Yamauchi PS, Bissonnette R, Teixeira HD, Valdecantos WC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-08-14

Titre: Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design.

Auteurs: Ports WC, Feldman SR, Gupta P, Tan H, Johnson TR, Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-07-15

Titre: Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.

Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-07-09

Titre: A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.

Auteurs: Gordon KB, Duffin KC, Bissonnette R, Prinz JC, Wasfi Y, Li S, Shen YK, Szapary P, Randazzo B, Reich K

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-05-16

Titre: Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE).

Auteurs: Thaçi D, Humeniuk J, Frambach Y, Bissonnette R, Goodman JJ, Shevade S, Gong Y, Papavassilis C; STATURE study group

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-05-08

Titre: Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.

Auteurs:

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-05-01

Titre: Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials

Auteurs: Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Kraft J, Lynde C, Gulliver W, Keeling S, Dutz J, Pope JE

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2015-04-02

Titre: Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

Auteurs: Bissonnette R, Iversen L, Sofen H, Griffiths CE, Foley P, Romiti R, Bachinsky M, Rottinghaus ST, Tan H, Proulx J, Valdez H, Gupta P, Mallbris L, Wolk R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-03-24

Titre: IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies.

Auteurs: Blauvelt A, Lebwohl MG, Bissonnette R

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2015-03-16

Titre: Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.

Auteurs: Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-03-09

Titre: Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr Boers.

Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2015-02-28

Titre: A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)

Auteurs: Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Toole J, Vieira A, Poulin-Costello M

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-01-21

Titre: Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE.

Auteurs: Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Garces K, Toole J, Poulin-Costello M

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-01-20

Titre: Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.

Auteurs: Bissonnette R, Maari C, Barber K, Lynde CW, Vender R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2015-01-05

Titre: The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2014-12-10

Titre: Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review.

Auteurs: Fleming P, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B, Gulliver WP

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2014-10-01

Titre: Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.

Auteurs: Bissonnette R, Nigen S, Langley RG, Lynde CW, Tan J, Fuentes-Duculan J, Krueger JG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2014-08-28

Titre: Changes in serum free testosterone, sleep patterns, and 5-alpha-reductase type I activity influence changes in sebum excretion in female subjects.

Auteurs: Bissonnette R, Risch JE, McElwee KJ, Marchessault P, Bolduc C, Nigen S, Maari C

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2014-08-26

Titre: Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis.

Auteurs: Tan J, Maari C, Nigen S, Bolduc C, Bissonnette R

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2014-07-01

Titre: A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE).

Auteurs: Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Toole J, Vieira A, Poulin-Costello M

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2014-06-01

Titre: Treatment of notalgia paresthetica with botulinum toxin A: a double-blind randomized controlled trial.

Auteurs: Maari C, Marchessault P, Bissonnette R

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2013-12-01

Titre: Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study.

Auteurs: Kimball AB, Papp KA, Wasfi Y, Chan D, Bissonnette R, Sofen H, Yeilding N, Li S, Szapary P, Gordon KB; PHOENIX 1 Investigators

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2013-11-01

Titre: Risk of myocardial infarction in Canadian patients with psoriasis: a retrospective cohort study.

Auteurs: Levesque A, Lachaine J, Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2013-07-16

Titre: A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.

Auteurs: Ports WC, Khan S, Lan S, Lamba M, Bolduc C, Bissonnette R, Papp K

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2013-04-13

Titre: Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy.

Auteurs: Basset-Seguin N, Bissonnette R, Girard C, Haedersdal M, Lear JT, Paul C, Piaserico S

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2013-01-01

Titre: Effects of the tumor necrosis factor-? antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial.

Auteurs: Bissonnette R, Tardif JC, Harel F, Pressacco J, Bolduc C, Guertin MC

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2012-12-26

Titre: Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial.

Auteurs: Bissonnette R, Bolduc C, Maari C, Nigen S, Webster JM, Tang L, Lyle M

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2012-12-06

Titre: Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.

Auteurs: Bissonnette R, Bolduc C, Maari C, Nigen S

Categorie: Actinic Keratoses


Lire cette publication sur PUBMED

Date: 2012-10-28

Titre: Influence of the quantity of sunscreen applied on the ability to protect against ultraviolet-induced polymorphous light eruption.

Auteurs: Bissonnette R, Nigen S, Bolduc C

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2012-09-26

Titre: Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology.

Auteurs: Braathen LR, Morton CA, Basset-Seguin N, Bissonnette R, Gerritsen MJ, Gilaberte Y, Calzavara-Pinton P, Sidoroff A, Wulf HC, Szeimies RM

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2012-09-19

Titre: Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial.

Auteurs: Maari C, Bolduc C, Nigen S, Marchessault P, Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2012-08-23

Titre: A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept.

Auteurs: Lynde CW, Gupta AK, Guenther L, Poulin Y, Levesque A, Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2012-08-11

Titre: A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.

Auteurs: Lui H, Gulliver W, Tan J, Hong CH, Hull P, Shear NH, Paradiso-Hardy F, Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2012-07-16

Titre: Safety and efficacy of adalimumab for the treatment of severe alopecia areata: case series of three patients.

Auteurs: Bolduc C, Bissonnette R

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2012-06-26

Titre: Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology.

Auteurs: Wiegell SR, Wulf HC, Szeimies RM, Basset-Seguin N, Bissonnette R, Gerritsen MJ, Gilaberte Y, Calzavara-Pinton P, Morton CA, Sidoroff A, Braathen LR

Categorie: Actinic Keratoses


Lire cette publication sur PUBMED

Date: 2012-04-16

Titre: Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial.

Auteurs: Bissonnette R, Poulin Y, Zhou Y, Tan J, Hong HC, Webster J, Ip W, Tang L, Lyle M

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2012-02-26

Titre: Psoriasis: Why Does it Come With a Greater Risk of Heart Attack and Stroke?

Auteurs: Bissonnette R

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2012-02-06

Titre: Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population.

Auteurs: Papp KA, Poulin Y, Bissonnette R, Bourcier M, Toth D, Rosoph L, Poulin-Costello M, Setterfield M, Syrotuik J

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2011-12-25

Titre: Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study.

Auteurs: Bissonnette R, Poulin Y, Guenther L, Lynde CW, Bolduc C, Nigen S

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2011-12-14

Titre: Treatment of acne with photodynamic therapy.

Auteurs: Bissonnette R

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2011-11-08

Titre: Fatigue and quality of sleep in patients with immune-mediated inflammatory disease.

Auteurs: Graff LA, Walker JR, Russell AS, Bissonnette R, Bernstein CN

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2011-11-08

Titre: Validity of quality of life measurement tools--from generic to disease-specific.

Auteurs: Wells GA, Russell AS, Haraoui B, Bissonnette R, Ware CF

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2011-11-03

Titre: Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability.

Auteurs: Jacobs P, Bissonnette R, Guenther LC

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2011-09-10

Titre: Randomized trial comparing a chemical peel containing a lipophilic hydroxy acid derivative of salicylic acid with a salicylic acid peel in subjects with comedonal acne.

Auteurs: Levesque A, Hamzavi I, Seite S, Rougier A, Bissonnette R

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2011-08-15

Titre: Support needed to involve psoriasis patients in treatment decisions: survey of dermatologists.

Auteurs: Tan J, Stacey D, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Bhatti S

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2011-05-15

Titre: Short incubation methylaminolevulinate photodynamic therapy without occlusion for the treatment of actinic keratoses

Auteurs: Robert Bissonnette, MD, FRCPC Simon Nigen, MD, FRCPC Chantal Bolduc, MD, FRCPC Catherine Maari, MD, FRCPC

Categorie: Actinic Keratoses


Lire cette publication sur PUBMED

Date: 2011-03-03

Titre: An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.

Auteurs: Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2010-12-14

Titre: Canadian hand dermatitis management guidelines.

Auteurs: Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, Agner T, Barber K, Bissonnette R, Ho V, Shear NH, Toole J

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2010-11-09

Titre: Photodynamic therapy with methylaminolevulinate 80 mg/g without occlusion improves acne vulgaris.

Auteurs: Bissonnette R, Maari C, Nigen S, Provost N, Bolduc C

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2010-10-14

Titre: Treatment decision needs of psoriasis patients: cross-sectional survey.

Auteurs: Tan J, Stacey D, Fung K, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Jackson C, Zhang X

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2010-07-04

Titre: Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies.

Auteurs: Langley RG, Papp K, Bissonnette R, Toth D, Matheson R, Hultquist M, White B

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2010-05-24

Titre: Redefining treatment options in chronic hand eczema (CHE).

Auteurs: Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown R, Homey B, Luger T, Lynde C, Maares J, Maibach HI

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2010-05-21

Titre: Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.

Auteurs: Poulin Y, Papp K, Bissonnette R, Barber K, Kerrouche N, Villemagne H; Calepso Study Team

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2010-05-20

Titre: Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept.

Auteurs: Bissonnette R, Bolduc C, Poulin Y, Guenther L, Lynde CW, Maari C

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2010-04-14

Titre: Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.

Auteurs: Bissonnette R, Chen G, Bolduc C, Maari C, Lyle M, Tang L, Webster J, Zhou Y

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2010-03-09

Titre: A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.

Auteurs: Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, Seite S

Categorie: Dermatitis (toutes)


Lire cette publication sur PUBMED

Date: 2010-03-06

Titre: A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis.

Auteurs: Bissonnette R, Papp K, Maari C, Yao Y, Robbie G, White WI, Le C, White B

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2010-02-01

Titre: Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.

Auteurs: Bissonnette R, Worm M, Gerlach B, Guenther L, Cambazard F, Ruzicka T, Maares J, Brown TC

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2010-01-08

Titre: Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.

Auteurs: Poulin Y, Papp K, Bissonnette R, Guenther L, Tan J, Lynde C, Kerrouche N, Villemagne H; CalePso Study Team

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2009-12-13

Titre: The next phase of real-world clinical experience with alefacept: the AWARE-2 registry

Auteurs: Searles G, Bissonnette R, Landells I, Shear NH

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2009-12-13

Titre: Efficacy outcomes in patients using alefacept in the AWARE study

Auteurs: Landells I, Searles G, Bissonnette R, Shear NH, Vender R, Lui H

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2009-12-13

Titre: Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study

Auteurs: Searles G, Bissonnette R, Landells I, Shear NH, Papp K, Lui H

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2009-12-13

Titre: Update on alefacept safety

Auteurs: Wexler D, Searles G, Landells I, Shear NH, Bissonnette R, Papp K, Poulin Y, Langley R, Gulliver WP

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2009-12-13

Titre: Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study

Auteurs: Searles G, Bissonnette R, Landells I, Shear NH

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2009-12-13

Titre: The AWARE study: methodology and baseline characteristics.

Auteurs: Bissonnette R, Searles G, Landells I, Shear NH, Papp K, Lui H, Gulliver WP, Lynde C

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2009-10-13

Titre: Safety of conventional systemic agents and biologic agents in the treatment of psoriasis.

Auteurs: Bissonnette R, Ho V, Langley RG

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2009-07-30

Titre: Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.

Auteurs: Bissonnette R, Langley RG, Papp K, Matheson R, Toth D, Hultquist M, Geba GP, White B

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2009-03-08

Titre: Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris.

Auteurs: Bissonnette R, Bolduc C, Seité S, Nigen S, Provost N, Maari C, Rougier A

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2008-10-12

Titre: Efficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis.

Auteurs: Bissonnette R, Nigen S, Bolduc C

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2008-10-07

Titre: Etanercept in the treatment of palmoplantar pustulosis.

Auteurs: Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, Poulin-Costello CM, Nigen S

Categorie: Autres


Lire cette publication sur PUBMED

Date: 2008-09-15

Titre: Protection afforded by sunscreens containing inorganic sunscreening agents against blue light sensitivity induced by aminolevulinic acid

Auteurs: Bissonnette R, Nigen S, Bolduc C, Méry S, Nocera T

Categorie: Acné


Lire cette publication sur PUBMED

Date: 2008-06-12

Titre: Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head.

Auteurs: Rivers JK, Rosoph L, Provost N, Bissonnette R

Categorie: Actinic Keratoses


Lire cette publication sur PUBMED

Date: 2008-04-19

Titre: Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study.

Auteurs: Papp K, Bissonnette R, Rosoph L, Wasel N, Lynde CW, Searles G, Shear NH, Huizinga RB, Maksymowych WP

Categorie: Psoriasis


Lire cette publication sur PUBMED

Date: 2008-04-15

Titre: Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.

Auteurs:

Categorie: Eczema


Lire cette publication sur PUBMED

Date: 2004-02-03

Titre: Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond

Auteurs: Bergeron A, Bissonnette R, Liu Y

Categorie: Actinic Keratoses


Lire cette publication sur PUBMED